PDA Requests Pause to USP’s Biologics Nomenclature Proposal

Earlier this year, PDA sent comments to the U.S. Pharmacopeia in response to a General Notices revision proposed in the Pharmacopeial Forum. PDA requested that USP pause the proposal to add a sentence regarding “biologics nomenclature and official titles” for further discussion, which could be led by PDA.